Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Accounts Payables (2016 - 2025)

Historic Accounts Payables for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to $2.7 million.

  • iBio's Accounts Payables rose 33224.76% to $2.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.7 million, marking a year-over-year increase of 33224.76%. This contributed to the annual value of $2.2 million for FY2025, which is 51117.32% up from last year.
  • According to the latest figures from Q4 2025, iBio's Accounts Payables is $2.7 million, which was up 33224.76% from $2.8 million recorded in Q3 2025.
  • iBio's 5-year Accounts Payables high stood at $5.3 million for Q1 2022, and its period low was $358000.0 during Q2 2024.
  • In the last 5 years, iBio's Accounts Payables had a median value of $2.1 million in 2023 and averaged $2.4 million.
  • Per our database at Business Quant, iBio's Accounts Payables crashed by 8063.82% in 2024 and then skyrocketed by 51117.32% in 2025.
  • Over the past 5 years, iBio's Accounts Payables (Quarter) stood at $2.7 million in 2021, then soared by 46.11% to $4.0 million in 2022, then plummeted by 53.55% to $1.9 million in 2023, then plummeted by 66.97% to $614000.0 in 2024, then surged by 332.25% to $2.7 million in 2025.
  • Its Accounts Payables was $2.7 million in Q4 2025, compared to $2.8 million in Q3 2025 and $2.2 million in Q2 2025.